GGrantIndex
← Leaderboards

Mayo Clinic Jacksonville

Jacksonville, FL

Compare ↔
$559,882,460
Total funding
372
Grants

Funding over time

peak $77.1M · FY2005–25
$100M$75M$50M$25M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$570,561,607 · 373

By mechanism

R01$252,047,882 · 138
U01$88,576,516 · 8
U19$60,300,990 · 24
RF1$33,911,193 · 11
R21$25,688,785 · 68
P01$24,058,823 · 19

Investigators at Mayo Clinic Jacksonville

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Cindy Tofthagen$2,976,2482 gr2Fouad T Chebib$2,967,6571 gr3Nadine Norton$2,772,1503 gr4Seiko Ikezu$2,629,3962 gr5Sandro Da Mesquita$2,250,7451 gr6Yan Bi$1,157,3181 gr7Paula V Schiapparelli$402,4011 gr8Ronnie Sebro$391,6691 gr

Emerging Leaders

6–10 yrs in

1Melissa Erin Murray$9,058,8943 gr2Na Zhao$8,172,7924 gr3Mark T W Ebbert$5,486,6302 gr4Betty Kim$3,814,2714 gr5Kathryn Jean Ruddy$3,623,1913 gr6Ying Wang$2,663,3482 gr7Matthew Stephen Block$2,034,6633 gr8Joy Wolfram$1,077,8112 gr

All-Time

Most funded here, all years

1Leonard Petrucelli$23,896,01514 gr2Debabrata Mukhopadhyay$18,175,4787 gr3Jungsu Kim$16,880,5999 gr4Andrew J Saykin$14,228,1119 gr5Lea Tenenholz Grinberg$13,505,1498 gr6Nilufer Ertekin-Taner$13,425,4515 gr7Wilfried Rossoll$12,130,29911 gr8Alfredo Quinones-Hinojosa$10,648,05610 gr

Largest grants

CREST-2 Clinical Coordinating Center$13,280,995
U01 · FY2017 · NS
Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations$9,157,485
U19 · FY2025 · AG
Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations$8,291,222
U19 · FY2024 · AG
Centrally-linked longitudinal peripheral biomarkers of AD in multi-ethnic populations$8,248,338
U19 · FY2023 · AG
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)$6,951,418
U01 · FY2021 · NS
Biology and pathobiology of apoE in aging and Alzheimer's disease$6,820,292
U19 · FY2021 · AG
Biology and pathobiology of apoE in aging and Alzheimer's disease$6,571,383
U19 · FY2022 · AG
Biology and pathobiology of apoE in aging and Alzheimer's disease$6,523,942
U19 · FY2023 · AG
Biology and pathobiology of apoE in aging and Alzheimer's disease$6,474,838
U19 · FY2024 · AG
CREST-2 Clinical Coordinating Center$6,297,501
U01 · FY2016 · NS
Biology and pathobiology of apoE in aging and Alzheimer's disease$6,293,390
U19 · FY2025 · AG
Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (SEA-NOBI-ALS)$6,133,297
U01 · FY2024 · NS
CREST-2 Clinical Coordinating Center$6,131,342
U01 · FY2018 · NS
Scalable Expanded Access with Analysis of Neurofilament and Other Biomarkers for Ibudilast in ALS (SEA-NOBI-ALS)$5,712,981
U01 · FY2025 · NS
Integrative translational discovery of vascular risk factors in aging and dementia$5,327,310
RF1 · FY2015 · AG
CREST-2 Clinical Coordinating Center$4,678,363
U01 · FY2015 · NS
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)$4,512,527
U01 · FY2022 · NS
CREST-2 Clinical Coordinating Center$4,069,399
U01 · FY2020 · NS
Omics Core$4,066,087
U19 · FY2023 · AG
Omics Core$4,010,080
U19 · FY2024 · AG